This inventor holds 10 USPTO granted patents and 1 published patent application. Top assignees: Cornell University, Genvec, Inc., Other. Active years: 1998-2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- New York, NY (US) (2004)
- Dobbs Ferry, NY (US) (1998 - 2007)
Company Filing History:
8 out of 2,949 
3 out of 88 
2 out of 834,453 Years Active: 1998-2007
Title: The Innovative Contributions of Erik S Falck-Pedersen
Introduction
Erik S Falck-Pedersen is a notable inventor based in Dobbs Ferry, NY (US). He has made significant contributions to the field of biotechnology, particularly in the development of adenoviral vectors. With a total of 10 patents to his name, his work has advanced the understanding and application of gene therapy.
Latest Patents
One of his latest patents is titled "Adenoviral vector with replication-dependent transgene expression." This invention provides an adenoviral vector that includes a major late transcription unit containing a terminal exon. The terminal exon comprises a 5' splice acceptor DNA sequence element and a 3' polyadenylation signal sequence. The vector also contains a non-native nucleic acid sequence encoding a protein that does not contribute to the adenoviral vector's entry into a host cell. This non-native nucleic acid sequence is selectively expressed in cells where the adenoviral vector can replicate. The invention further includes a method for treating or preventing a pathologic state in mammals using this adenoviral vector composition.
Another significant patent is the "Adenovirus gene expression system." This invention involves an adenoviral vector that has at least one insertion site for cloning a heterologous gene. It also features a heterologous promoter positioned upstream from the insertion site and a eukaryotic splice acceptor and splice donor site between the promoter and the insertion site. Additionally, a polyadenylation sequence is positioned downstream of the insertion site. This invention provides a method of producing a selected protein and delivering a heterologous gene to an animal heart.
Career Highlights
Erik S Falck-Pedersen has worked with prominent organizations such as Cornell Research Foundation Inc. and Genvec, Inc. His experience in these institutions has allowed him to collaborate on various innovative projects that have contributed to advancements in gene therapy and biotechnology.
Collaborations
Some of his notable coworkers include Thomas J Wickham and Jason Gall. Their collaborative efforts have further enhanced the impact of his inventions in the field.
Conclusion
Erik S Falck-Pedersen's contributions to biotechnology through his innovative patents and collaborations have significantly advanced the field of gene therapy. His work continues to influence research and applications in this vital area of science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile